View Item 

Show simple item record

The use of aprotinin in children undergoing operative repair of isolated atrial septal defects
dc.contributor.authorChiravuri, Srinivas Devi.en_US
dc.contributor.authorVoepel-Lewis, Terrien_US
dc.contributor.authorDevaney, Eric J.en_US
dc.contributor.authorMalviya, Shobhaen_US
dc.date.accessioned2010-06-01T21:07:56Z
dc.date.available2010-06-01T21:07:56Z
dc.date.issued2008-02en_US
dc.identifier.citationCHIRAVURI, S. DEVI; VOEPEL-LEWIS, TERRI; DEVANEY, ERIC J.; MALVIYA, SHOBHA (2008). "The use of aprotinin in children undergoing operative repair of isolated atrial septal defects." Pediatric Anesthesia 18(2): 145-150. <http://hdl.handle.net/2027.42/74215>en_US
dc.identifier.issn1155-5645en_US
dc.identifier.issn1460-9592en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74215
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18184246&dopt=citationen_US
dc.format.extent78349 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Authors Journal compilation 2007 Blackwell Publishing Ltden_US
dc.subject.otherAprotininen_US
dc.subject.otherChildrenen_US
dc.subject.otherAtrial Septal Defecten_US
dc.subject.otherCardiopulmonary Bypassen_US
dc.subject.otherTransfusionen_US
dc.titleThe use of aprotinin in children undergoing operative repair of isolated atrial septal defectsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid18184246en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74215/1/j.1460-9592.2007.02361.x.pdf
dc.identifier.doi10.1111/j.1460-9592.2007.02361.xen_US
dc.identifier.sourcePediatric Anesthesiaen_US
dc.identifier.citedreferenceArnold DM, Fergusson DA, Chan AK et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006; 102: 731 – 737.en_US
dc.identifier.citedreferenceHenry DA, Moxey AJ, Carless PA et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 3, 2007.en_US
dc.identifier.citedreferenceSedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004; 128: 442 – 448.en_US
dc.identifier.citedreferenceMangano DT, Tudor IC, Dietzel C et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353 – 365.en_US
dc.identifier.citedreferenceKarkouti K, Beattie WS, Dattilo KM et al. A propensity score case–control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006; 46: 327 – 338.en_US
dc.identifier.citedreferenceMangano DT, Miao Y, Vuylsteke A et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297: 471 – 479.en_US
dc.identifier.citedreferenceBoldt J, Knothe C, Zickmann B et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss (see comment). J Thorac Cardiovasc Surgery 1993; 105: 705 – 711.en_US
dc.identifier.citedreferenceD’Errico CC, Shayevitz JR, Martindale SJ et al. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 1996; 83: 1193 – 1199.en_US
dc.identifier.citedreferenceHerynkopf F, Lucchese F, Pereira E et al. Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study. J Thorac Cardiovasc Surg 1994; 108: 517 – 521.en_US
dc.identifier.citedreferenceMossinger H, Dietrich W, Braun SL et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003; 75: 430 – 437.en_US
dc.identifier.citedreferenceKern FH, Morana NJ, Sears JJ et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 541 – 546.en_US
dc.identifier.citedreferenceNaik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion 1991; 6: 41 – 650.en_US
dc.identifier.citedreferenceLevy JH. Hemostatic agents and their safety. J Cardiothorac Vasc Anesth 1999; 13: 6 – 11.en_US
dc.identifier.citedreferenceDietrich W. Incidence of hypersensitivity reactions. Ann Thorac Surg 1998; 65: S60 – S64.en_US
dc.identifier.citedreferenceCohen DM, Norberto J, Cartabuke R et al. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg 1999; 67: 837 – 838.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1460-9592.2007.02361.x.pdf
Size:
76.51KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.